The forecasted asthma mortality in Canada for women from 2024 to 2028 remains consistently at 900 female deaths per hundred women. Having the same figures repeated annually indicates stability with no growth or decline in mortality projections. This stability reflects health system strategies effectively maintaining control over asthma-related challenges, possibly due to continued improvements in healthcare management and interventions from current levels observed in 2023.
Future trends to watch for include the potential impact of new medical technologies and pharmaceuticals that may lower mortality rates. Additionally, shifts in environmental conditions, policy changes, and public health initiatives could influence these projections. Monitoring these factors will be crucial to anticipate changes in asthma mortality rates effectively.
